Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Director acquired 1,000 shares (grant or award)
  3. 4 Grant or award Director acquired 1,000 shares (grant or award)
  4. 4 Grant or award Director acquired 5,000 shares (grant or award)
  5. 4 Shares withheld for taxes VP and Chief Compliance Office gave up 1,280 shares (to pay taxes)
  6. 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
  7. 4 Grant or award Director acquired 1,000 shares (grant or award)
  8. 4 Shares withheld for taxes Chairman and CEO gave up 37,205 shares (to pay taxes)
  9. 4 Open-market buy Director bought 423 shares at an average $4.56 ($1,930)
  10. 4 Open-market buy Director bought 394 shares at an average $4.54 ($1,790)
  11. 4 Open-market buy Chairman and CEO bought 394 shares at an average $4.54 ($1,790)
  12. 4 Open-market buy Director bought 1,956 shares at an average $4.51 ($8,817)
  13. 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,114 shares at an average $4.53 ($9,571)
  14. 4 Open-market buy Chief Financial Officer bought 3,800 shares at $2.35 ($8,930)
  15. 4 Open-market buy Director bought 284 shares at an average $2.65 ($753)
  16. 4 Open-market buy Director bought 882 shares at an average $2.72 ($2,402)
  17. 4 Open-market buy Director bought 395 shares at an average $2.75 ($1,086)
  18. 4 Open-market buy Chairman and CEO bought 395 shares at an average $2.75 ($1,086)
  19. 4 Open-market buy Director bought 2,045 shares at an average $2.74 ($5,605)
  20. 4 Open-market buy Sr VP/Chief Commercial Officer bought 2,485 shares at an average $2.74 ($6,803)

Page 10 of 26 · 512 filings